Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on November 30, 2018. The filing reports the entry into a material definitive agreement and the formal appointment of a new Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change reported is the formalization of Kevin Richardson's role as Chief Executive Officer (CEO), effective November 30, 2018. Prior to this date, Mr. Richardson served as the Acting CEO and Chairman of the Board. He continues to serve as Chairman.
Management Commentary and Compensation Details
Under the new Employee/Employer Agreement, the following compensation terms were established for Mr. Richardson:
- Base Salary: $350,000 annually, subject to change based on performance reviews.
- Annual Bonus: Eligible for up to 100% of the annual base salary contingent on performance goals.
- Sign-on Bonus: A one-time payment of $145,833.33 if specific company goals are met.
- Term: The agreement runs until December 31, 2019, with automatic year-to-year renewal unless terminated by either party 30 days prior to the renewal date.
- Restrictions: Includes a non-compete covenant for the term of employment plus two years and an indefinite confidentiality provision.
Investor Verification Checklist
- Verify the full text of the Offer Letter filed as Exhibit 10.1 for specific performance metrics tied to the bonus structure.
- Confirm the company's current cash position to assess the ability to fund the $145,833.33 sign-on bonus and increased annual salary obligations.
- Review subsequent filings to determine if the performance goals for the sign-on bonus were achieved.
- Check for any related party transaction disclosures regarding Mr. Richardson's prior role as managing partner of Prides Capital LLC.